Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)
- 1 January 1999
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (2) , 210-212
- https://doi.org/10.1021/jm9806648
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Mechanisms mediating cancer cachexiaCancer, 1995
- Androgen and progestagen effects on plasma lipidsProgress in Cardiovascular Diseases, 1995
- Global Sea Level and Earth RotationScience, 1988
- Reduction of heterocyclic compounds. II. Reduction of heterocyclic compounds with sodium borohydride-transition metal salt systems.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Coupling step in solid phase peptide synthesis. Further competition experiments and attempts to assess formation of ion pairsThe Journal of Organic Chemistry, 1974
- Selective metalations of methylated pyridines and quinolines. Condensation reactionsThe Journal of Organic Chemistry, 1973
- The Bacterial Activity of “Racemized Casein,” Caseose, and the Four Diastereoisomeric Leucylleucines1,2Journal of the American Chemical Society, 1948
- Synthetische Versuche mit dem AcetessigesterEuropean Journal of Organic Chemistry, 1886